Mapping health assessment questionnaire disability index onto EQ-5D-5L in China

Objective This research aimed to develop the more accurate mapping algorithms from health assessment questionnaire disability index (HAQ-DI) onto EQ-5D-5L based on Chinese Rheumatoid Arthritis patients. Methods The cross-sectional data of Chinese RA patients from 8 tertiary hospitals across four provincial capitals was used for constructing the mapping algorithms. Direct mapping using Ordinary least squares regression (OLS), the general linear regression model (GLM), MM-estimator model (MM), Tobit regression model (Tobit), Beta regression model (Beta) and the adjusted limited dependent variable mixture model (ALDVMM) and response mapping using Multivariate Ordered Probit regression model (MV-Probit) were carried out. HAQ-DI score, age, gender, BMI, DAS28-ESR and PtAAP were included as the explanatory variables. The bootstrap was used for validation of mapping algorithms. The average ranking of mean absolute error (MAE), root mean square error (RMSE), adjusted R2 (adjR2) and concordance correlation coefficient (CCC) were used to assess the predictive ability of the mapping algorithms. Results According to the average ranking of MAE, RMSE, adjR2, and CCC, the mapping algorithm based on Beta performed the best. The mapping algorithm would perform better as the number of variables increasing. Conclusion The mapping algorithms provided in this research can help researchers to obtain the health utility values more accurately. Researchers can choose the mapping algorithms under different combinations of variables based on the actual data.

[1]  N. Luo,et al.  Mapping the obesity problems scale to the SF-6D: results based on the Scandinavian Obesity Surgery Registry (SOReg) , 2022, The European Journal of Health Economics.

[2]  P. McNamee,et al.  Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data , 2022, The European Journal of Health Economics.

[3]  Shuyang Zhang,et al.  Mapping the Haem-A-QoL to the EQ-5D-5L in patients with hemophilia , 2021, Quality of Life Research.

[4]  X. Zeng,et al.  [The challenges and opportunities for the management of rheumatoid arthritis in China: an annual report of 2019]. , 2021, Zhonghua nei ke za zhi.

[5]  Shuyang Zhang,et al.  Mapping of the acromegaly quality of life questionnaire to ED-5D-5L index score among patients with acromegaly , 2021, The European Journal of Health Economics.

[6]  S. Ye,et al.  Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World , 2020, Journal of inflammation research.

[7]  E. Wong,et al.  Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas , 2020, The European Journal of Health Economics.

[8]  Jingyang Li,et al.  Cost-effectiveness of Anbainuo plus methotrexate compared to conventional disease-modifying antirheumatic drugs for rheumatoid arthritis patients in China , 2020, Annals of translational medicine.

[9]  Chuan Yu,et al.  [Evaluation of Reliability and Validity of EQ-5D-5L Based on Residents in Southwest China]. , 2020, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[10]  N. Kragh,et al.  Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study , 2020, Quality of Life Research.

[11]  S. Ghabri,et al.  Systematic Literature Review of Economic Evaluations of Biological Treatment Sequences for Patients with Moderate to Severe Rheumatoid Arthritis Previously Treated with Disease-Modifying Anti-rheumatic Drugs , 2020, PharmacoEconomics.

[12]  P. Dixon,et al.  Mapping to Quality of Life and Capability Measures in Cataract Surgery Patients: From Cat-PROM5 to EQ-5D-3L, EQ-5D-5L, and ICECAP-O Using Mixture Modelling , 2020, MDM policy & practice.

[13]  Zhichao Shi,et al.  Cost-effectiveness analysis of etanercept plus methotrexate vs triple therapy in treating Chinese rheumatoid arthritis patients , 2020, Medicine.

[14]  P. Cheung,et al.  Sociodemographic factors as determinants of disease, disability and quality of life trajectories in early rheumatoid arthritis: A multi‐ethnic inception cohort study , 2019, International journal of rheumatic diseases.

[15]  Jingyang Li,et al.  A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients , 2019, Medicine.

[16]  J. Piercy,et al.  Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis , 2019, The European Journal of Health Economics.

[17]  A. Wailoo,et al.  Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[18]  Luan Luan,et al.  Mapping between HAQ-DI and EQ-5D-5L in a Chinese patient population , 2018, Quality of Life Research.

[19]  K. Pavelka,et al.  Mapping Quality of Life (EQ-5D) from DAPsA, Clinical DAPsA and HAQ in Psoriatic Arthritis , 2018, The Patient - Patient-Centered Outcomes Research.

[20]  A. Wailoo,et al.  Development of Methods for the Mapping of Utilities Using Mixture Models: Mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in Patients with Asthma , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[21]  E. Galíndez,et al.  THU0109 Updated estimation of the EQ5D quality of life questionnaire utility values through HAQ-DI mapping for spain , 2017 .

[22]  A. Hawton,et al.  Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values , 2017, PharmacoEconomics - Open.

[23]  Wendong Chen,et al.  Real-world cost-effectiveness of infliximab for moderate-to-severe rheumatoid arthritis in a medium-sized city of China. , 2017, Journal of comparative effectiveness research.

[24]  Nan Luo,et al.  Estimating an EQ-5D-5L Value Set for China. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[25]  Liren Li,et al.  The correlations of socioeconomic status, disease activity, quality of life, and depression/anxiety in Chinese patients with rheumatoid arthritis , 2017, Psychology, health & medicine.

[26]  I. McInnes,et al.  Rheumatoid arthritis , 2016, The Lancet.

[27]  S. Bang,et al.  Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data , 2016, Rheumatology International.

[28]  J. Richardson,et al.  Mapping between 6 Multiattribute Utility Instruments , 2016, Medical decision making : an international journal of the Society for Medical Decision Making.

[29]  N. Luo,et al.  Valuing Health-Related Quality of Life in Type 2 Diabetes Patients in China , 2016, Medical decision making : an international journal of the Society for Medical Decision Making.

[30]  Michael Herdman,et al.  Interpretation and use of the 5-level EQ-5D response labels varied with survey language among Asians in Singapore. , 2015, Journal of clinical epidemiology.

[31]  Mark Oppe,et al.  The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration , 2015, PharmacoEconomics.

[32]  Andrea Manca,et al.  Prediction of patient‐reported outcome measures via multivariate ordered probit models , 2015 .

[33]  J. Brazier,et al.  Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. , 2014, Health technology assessment.

[34]  J. Thompson,et al.  Use of Bayesian Multivariate Meta-Analysis to Estimate the HAQ for Mapping Onto the EQ-5D Questionnaire in Rheumatoid Arthritis , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[35]  Allan Wailoo,et al.  The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis , 2013, Rheumatology.

[36]  J. Zajicek,et al.  Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[37]  Matthias Hunger,et al.  Longitudinal beta regression models for analyzing health-related quality of life scores over time , 2012, BMC Medical Research Methodology.

[38]  Roberta Ara,et al.  Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[39]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[40]  Andrea Manca,et al.  Regression Estimators for Generic Health-Related Quality of Life and Quality-Adjusted Life Years , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[41]  Donna Rowen,et al.  Mapping onto Eq-5 D for patients in poor health , 2010, Health and quality of life outcomes.

[42]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[43]  Aki Tsuchiya,et al.  A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures , 2010, The European Journal of Health Economics.

[44]  T. Tasiemski,et al.  Assessment of objective and subjective quality of life in people with rheumatoid arthritis - preliminary study. , 2009, Ortopedia, traumatologia, rehabilitacja.

[45]  C. Croux,et al.  Robust Regression in Stata , 2008 .

[46]  Vahram Ghushchyan,et al.  Mapping the EQ-5D Index from the SF-12: US General Population Preferences in a Nationally Representative Sample , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[47]  A. Boyles,et al.  National Institute of Environmental Health Sciences , 2008 .

[48]  J. Pater Quality of life and pharmacoeconomics in clinical trials , 1996 .

[49]  V. Yohai HIGH BREAKDOWN-POINT AND HIGH EFFICIENCY ROBUST ESTIMATES FOR REGRESSION , 1987 .

[50]  D. H. Lee,et al.  The National Institute of Environmental Health Sciences. , 1970, American Industrial Hygiene Association journal.

[51]  G. K. Hirst British Medical Journal , 1927 .

[52]  H. Hasegawa Assessment of Disease Activity, Structural Damage, and Function in Rheumatoid Arthritis. , 2018, Methods in molecular biology.

[53]  [2018 Chinese guideline for the diagnosis and treatment of rheumatoid arthritis]. , 2018, Zhonghua nei ke za zhi.

[54]  Andrea Manca,et al.  Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[55]  Xie Xiao-ping Disease Burden and Quality of Life of Rheumatoid Arthritis in China: A Systematic Review , 2013 .

[56]  X. Badia,et al.  Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[57]  Patrick W. Sullivan,et al.  US General Population Preferences in a Nationally Representative Sample , 2009 .

[58]  P. Fayers,et al.  Quality of Life: The assessment, analysis and interpretation of patient-reported outcomes , 2007 .

[59]  J. Fries,et al.  The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. , 2003, The Journal of rheumatology.

[60]  M. Prevoo,et al.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[61]  C. L. Callahan,et al.  The quality of life. , 1970, Nursing outlook.

[62]  Douglas G. Altman,et al.  Explanation and Elaboration , 2022 .